291 related articles for article (PubMed ID: 29086069)
21. Clinical correlates of sleep problems in systemic sclerosis: the prominent role of pain.
Milette K; Razykov I; Pope J; Hudson M; Motivala SJ; Baron M; Thombs BD
Rheumatology (Oxford); 2011 May; 50(5):921-5. PubMed ID: 21169344
[TBL] [Abstract][Full Text] [Related]
22. Quality of life and correlation with musculoskeletal problems, hand disability and depression in patients with hemodialysis.
Fidan F; Alkan BM; Tosun A; Altunoğlu A; Ardıçoğlu Ö
Int J Rheum Dis; 2016 Feb; 19(2):159-66. PubMed ID: 24176031
[TBL] [Abstract][Full Text] [Related]
23. The relationship between vascular biomarkers and disease characteristics in systemic sclerosis: elevated MCP-1 is predominantly associated with fibrotic manifestations.
Yalçinkaya Y; Çinar S; Artim-Esen B; Kamali S; Öcal L; Deniz G; Inanç M
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):110-114. PubMed ID: 27749243
[TBL] [Abstract][Full Text] [Related]
24. Impaired sexual function in women with systemic sclerosis: a cross-sectional study.
Schouffoer AA; van der Marel J; Ter Kuile MM; Weijenborg PT; Voskuyl A; Vliet Vlieland CW; van Laar JM; Vliet Vlieland TP
Arthritis Rheum; 2009 Nov; 61(11):1601-8. PubMed ID: 19877108
[TBL] [Abstract][Full Text] [Related]
25. Common Causes of Pain in Systemic Sclerosis: Frequency, Severity, and Relationship to Disease Status, Depression, and Quality of Life.
Ostojic P; Jankovic K; Djurovic N; Stojic B; Knezevic-Apostolski S; Bartolovic D
Pain Manag Nurs; 2019 Aug; 20(4):331-336. PubMed ID: 31103501
[TBL] [Abstract][Full Text] [Related]
26. Determinants of disability, quality of life and depression in dermatological patients with systemic scleroderma.
Müller H; Rehberger P; Günther C; Schmitt J
Br J Dermatol; 2012 Feb; 166(2):343-53. PubMed ID: 21916888
[TBL] [Abstract][Full Text] [Related]
27. Malnutrition, associated clinical factors, and depression in systemic sclerosis: a cross-sectional study.
Türk İ; Cüzdan N; Çiftçi V; Arslan D; Doğan MC; Unal İ
Clin Rheumatol; 2020 Jan; 39(1):57-67. PubMed ID: 31129793
[TBL] [Abstract][Full Text] [Related]
28. The impact of systemic sclerosis on health-related quality of life assessed by SF-36: A systematic review and meta-analysis.
Li L; Cui Y; Chen S; Zhao Q; Fu T; Ji J; Li L; Gu Z
Int J Rheum Dis; 2018 Nov; 21(11):1884-1893. PubMed ID: 30428506
[TBL] [Abstract][Full Text] [Related]
29. Factors related to alexithymia in patients with systemic sclerosis: a tight relationship with facial image dissatisfaction.
Basta F; Margiotta DPE; Mazzuca C; Batani V; Dolcini G; Moras P; Vadacca M; Afeltra A
Rheumatol Int; 2019 Mar; 39(3):461-467. PubMed ID: 30498976
[TBL] [Abstract][Full Text] [Related]
30. Influence of cortisol and DHEA-S on pain and other symptoms in post menopausal women with fibromyalgia.
Freitas RP; Lemos TM; Spyrides MH; Sousa MB
J Back Musculoskelet Rehabil; 2012; 25(4):245-52. PubMed ID: 23220807
[TBL] [Abstract][Full Text] [Related]
31. The minimally important difference in clinical practice for patient-centered outcomes including health assessment questionnaire, fatigue, pain, sleep, global visual analog scale, and SF-36 in scleroderma.
Sekhon S; Pope J; ; Baron M
J Rheumatol; 2010 Mar; 37(3):591-8. PubMed ID: 20080913
[TBL] [Abstract][Full Text] [Related]
32. Pain Sensitivity in Patients With Major Depression: Differential Effect of Pain Sensitivity Measures, Somatic Cofactors, and Disease Characteristics.
Hermesdorf M; Berger K; Baune BT; Wellmann J; Ruscheweyh R; Wersching H
J Pain; 2016 May; 17(5):606-16. PubMed ID: 26867484
[TBL] [Abstract][Full Text] [Related]
33. Impact of pain in health related quality of life of patients with systemic sclerosis.
Georges C; Chassany O; Toledano C; Mouthon L; Tiev K; Meyer O; Ilie D; Rambeloarisoa J; Marjanovic Z; Cabane J; Sereni D; Pouchot J; Farge D
Rheumatology (Oxford); 2006 Oct; 45(10):1298-302. PubMed ID: 16754629
[TBL] [Abstract][Full Text] [Related]
34. Sacroiliac joint involvement in systemic sclerosis.
Arslan Tas D; Yıldız F; Sakallı H; Kelle B; Ballı T; Erken E
Int J Rheum Dis; 2015 Jan; 18(1):84-90. PubMed ID: 24807846
[TBL] [Abstract][Full Text] [Related]
35. Capillaroscopic findings and vascular biomarkers in systemic sclerosis: Association of low CD40L levels with late scleroderma pattern.
Yalçınkaya Y; Adın-Çınar S; Artim-Esen B; Kamalı S; Pehlivan Ö; Öcal L; Deniz G; Inanç M
Microvasc Res; 2016 Nov; 108():17-21. PubMed ID: 27392528
[TBL] [Abstract][Full Text] [Related]
36. Lower limb muscle strength is associated with functional performance and quality of life in patients with systemic sclerosis.
Lima TR; Guimarães FS; Carvalho MN; Sousa TL; Menezes SL; Lopes AJ
Braz J Phys Ther; 2015; 19(2):129-36. PubMed ID: 25789555
[TBL] [Abstract][Full Text] [Related]
37. Impaired quality of life in patients with systemic sclerosis compared to the general population and chronic dermatoses.
Bretterklieber A; Painsi C; Avian A; Wutte N; Aberer E
BMC Res Notes; 2014 Sep; 7():594. PubMed ID: 25183055
[TBL] [Abstract][Full Text] [Related]
38. Frequency and analysis of factors closely associated with the development of depressive symptoms in patients with scleroderma.
Matsuura E; Ohta A; Kanegae F; Haruda Y; Ushiyama O; Koarada S; Togashi R; Tada Y; Suzuki N; Nagasawa K
J Rheumatol; 2003 Aug; 30(8):1782-7. PubMed ID: 12913935
[TBL] [Abstract][Full Text] [Related]
39. Serum levels of monocyte chemotactic protein-3/CCL7 are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
Yanaba K; Komura K; Kodera M; Matsushita T; Hasegawa M; Takehara K; Sato S
Ann Rheum Dis; 2006 Jan; 65(1):124-6. PubMed ID: 16344498
[TBL] [Abstract][Full Text] [Related]
40. The Impact of Pain and Itch on Functioning and Health-Related Quality of Life in Systemic Sclerosis: An Exploratory Study.
Racine M; Hudson M; Baron M; Nielson WR;
J Pain Symptom Manage; 2016 Jul; 52(1):43-53. PubMed ID: 26876159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
